undamentalytics Newsletter
Sign in

Seer, Inc. (SEER) stock

Add to watchlist

Add holding +

NASDAQ: SEER Nasdaq Life Sciences Tools & Services Next results ~November 10, 2026

E Fundamentals grade

Seer, Inc. is a US-listed company in the life sciences tools & services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Seer, Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: free cash flow after stock pay is not positive. We'll show the comparison once resolved.

Seer, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 3 selling0 purchases and 7 sales by directors and officers, last 12 monthsInsider trades
  • Funds23 adding, 27 cuttingOf 13 active managers that changed their stake, 6 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Seer files

Where Seer stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $14m, down 12.7% on a year earlier, a steeper fall than the 0.9% decline a quarter earlier. That puts it 42 of 46 for growth among the life sciences tools & services companies we cover. Free-cash-flow margin rose to -311.1% from -334.8% a year earlier. Operating margin widened to -498.2% from -546.9%. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 2 of our 2 financial-health checks.

Our model value for Seer is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 11, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 10, 2026 (estimated)

Seer, Inc.'s trailing-twelve-month revenue fell 12.7% year on year, with a free-cash-flow margin of -311.1%. Where it lags: change in growth rate of -11.8pp ranks 51 of 54 life sciences tools & services companies we cover.

Current signal Revenue growth decelerating: TTM revenue growth slowed to -12.7% (-11.8pp vs the prior quarter), the 2nd consecutive quarterly slowdown.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 48.7 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Results due soon. Results are expected around 5 November; the share price can move sharply on the day.
  • Revenue shrinking. Revenue fell 12.7% over the last 12 months.
  • Growth slowing. The growth rate is 11.8 points lower than a quarter earlier.
  • Loss-making. Operating margin is -498.2%: costs exceed revenue.
  • Burning cash. Free cash flow was -311.1% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 74.3% of revenue, against a median of 4.4% for life sciences tools & services companies we cover: a real cost that cash-flow figures leave out.

Latest results: FY2026 Q2

Filed August 11, 2026
Earnings per share
-$0.31 against an average estimate of -$0.27: missed by 14.8%
Revenue
$3m, down 23.4% on a year earlier
Share reaction
-0.9% in the first session after the results on August 11, 2026, against -0.1% for the S&P 500
Next report
November 10, 2026; average EPS estimate -$0.26

Seer's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.0%
  • 1 week-10.4%
  • 1 month-23.1%
  • This year-5.5%
  • 1 year-21.7%
  • 5 years-95.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$14.2M
Operating margin
-498.2%
Net margin
-478.0%

Growth

Revenue growth
−12.7%
Change in growth rate
−11.8 pts

Cash

Free cash flow (TTM)
-$44.2M
FCF margin
-311.1%
Stock pay % of revenue
74.3%

Earnings

Last results
August 11, 2026
Next results (est.)
November 5, 2026

News & updates

Updated November 3, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Leadership
  3. Results
  4. Shareholder vote
  5. Announcement
  6. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Seer, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: free cash flow after stock pay is not positive.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Seer, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 9.7%: the 10-year Treasury yield (4.9%) plus a beta of 1.05 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: This model is withheld pending its input or assumption review.
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$0.3 ~$0.4–$1.6 Left out: out of range vs price (0.20x)
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Seer, Inc. with Life Sciences Tools & Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 2020202120222023
Share price$56.14$22.81$5.80$1.94
Market value$742m$1.4bn$362m$124m
+ Net debt (− = net cash)−$334m−$233m−$53m−$32m
Enterprise value$408m$1.2bn$309m$91m
Multiples
Price / sales n/mn/m23.4x7.4x
Price / earnings ————
Price / free cash flow ————
EV / EBITDA ————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

22 /100

Weak moat

How hard Seer's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -20.3% of total assets over 6 years.

  • Pricing power 12 / 20

    Gross margin has been a median 49.6%, moving by 7.3 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -657.6%; its worst year was -3028.0%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 6 years, at a median -393.8% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (27 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 10, 2026, after the close. Analysts expect revenue of $4m and EPS of −$0.26 (range −$0.27 to −$0.25) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$1.10 +14% $16m −3%
Next −$1.05 +4% $19m +21%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +5.3% on 90 days ago. In the last 30 days, 0 analysts raised Seer, Inc.'s forecast and 2 cut it.

Consensus EPS forecast Seer, Inc., last 90 days
−$1.50 −$1.00 −$0.50 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$1.04 Current fiscal year, 60 days ago: −$1.10 Current fiscal year, 30 days ago: −$1.10 Current fiscal year, 7 days ago: −$1.10 Current fiscal year, Now: −$1.10 −$1.10 Next fiscal year, 90 days ago: −$0.98 Next fiscal year, 60 days ago: −$1.02 Next fiscal year, 30 days ago: −$1.02 Next fiscal year, 7 days ago: −$1.02 Next fiscal year, Now: −$1.05 −$1.05

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$1.04−$0.98
60 days ago −$1.10−$1.02
30 days ago −$1.10−$1.02
7 days ago −$1.10−$1.02
Now −$1.10−$1.05

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.27 −$0.31 −14.8%
Mar 2026 −$0.29 −$0.30 −1.7%
Dec 2025 −$0.32 −$0.29 +9.4%
Sept 2025 −$0.30 −$0.32 −6.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

2 analysts, Oct 2026
Buy2100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202622
  2. Sep 202622

Counts of recommendations published by analysts covering Seer, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
0.2%
of tradable shares
Days to cover
0.31
at average volume
Short interest, 1 month
+8%
to October 15, 2026
Held by institutions
49%
of shares
Held by insiders
14.8%
of shares
Employees
124
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −21.7%

$2.21 on October 31, 2025 to $1.73

ThenNowEffect
Revenue (last 12 months) $16m $14m −12.7%
P/S multiple 8.6x 7.7x −10.3%
Share count 64m 64m 0.0%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

Last 3 years −4.9%

$1.82 on November 3, 2023 to $1.73

ThenNowEffect
Revenue (last 12 months) $17m $14m −14.5%
P/S multiple 6.9x 7.7x +11.9%
Share count 63m 64m −0.7%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
SEER−59%−75%−67%+19%−21%−6%
Industry peers (median)+5%−51%−3%−15%−2%+16%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
SEER58%42%33%50%42%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
SEER−75%−79%−75%−29%−33%−28%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since December 4, 2020: 98% from January 20, 2021 to November 16, 2023. Getting back needed a 5618% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$1.62 – $2.33
From 52-week high
−25.8%
vs 50-day average
−13.5%
vs 200-day average
−9.9%
Volatility (1 year)
56%
Beta vs S&P 500
1.03

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
3 up, 9 down
typical move ±6.3%
After a week
4 up, 8 down
typical move ±8.1%
After a month
3 up, 9 down
typical move ±12.3%
Results releasedNext dayS&P 500 next day5 days21 days
August 11, 2026 −0.9% −0.1% −6.5% −10.6%
May 13, 2026 −3.8% +1.4% −7.7% −5.5%
February 26, 2026 −17.7% −1.0% −12.0% −20.6%
November 6, 2025 −3.7% −1.0% −6.0% −14.7%
August 6, 2025 −5.2% +0.7% +2.4% −0.9%
May 13, 2025 +11.6% +0.8% +10.6% +12.7%
February 27, 2025 −7.9% −0.1% −12.3% −23.7%
November 6, 2024 +9.4% +3.3% +13.8% +22.2%
August 8, 2024 0.0% +2.8% −1.7% −5.8%
May 8, 2024 −6.8% +0.6% −3.2% −21.7%
February 29, 2024 +1.1% +1.3% +15.6% +3.9%
November 7, 2023 −7.4% +0.4% −5.7% −5.1%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Seer, Inc.
$14M $15M $16M $17M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $16.8M Revenue (TTM), FY23 Q4: $16.7M Revenue (TTM), FY24 Q1: $15.7M Revenue (TTM), FY24 Q2: $14.7M Revenue (TTM), FY24 Q3: $14.6M Revenue (TTM), FY24 Q4: $14.2M Revenue (TTM), FY25 Q1: $15.3M Revenue (TTM), FY25 Q2: $16.3M Revenue (TTM), FY25 Q3: $16.4M Revenue (TTM), FY25 Q4: $16.6M Revenue (TTM), FY26 Q1: $15.2M Revenue (TTM), FY26 Q2: $14.2M $14.2M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $16.8M
FY23 Q4 $16.7M
FY24 Q1 $15.7M
FY24 Q2 $14.7M
FY24 Q3 $14.6M
FY24 Q4 $14.2M
FY25 Q1 $15.3M
FY25 Q2 $16.3M
FY25 Q3 $16.4M
FY25 Q4 $16.6M
FY26 Q1 $15.2M
FY26 Q2 $14.2M
Revenue growth, TTM YoY Seer, Inc.
-20% -10% 0% 10% 20% 30% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 20.6% Revenue growth, TTM YoY, FY23 Q4: 7.5% Revenue growth, TTM YoY, FY24 Q1: -3.4% Revenue growth, TTM YoY, FY24 Q2: -11.3% Revenue growth, TTM YoY, FY24 Q3: -13.2% Revenue growth, TTM YoY, FY24 Q4: -15.0% Revenue growth, TTM YoY, FY25 Q1: -2.3% Revenue growth, TTM YoY, FY25 Q2: 10.5% Revenue growth, TTM YoY, FY25 Q3: 12.1% Revenue growth, TTM YoY, FY25 Q4: 17.0% Revenue growth, TTM YoY, FY26 Q1: -0.9% Revenue growth, TTM YoY, FY26 Q2: -12.7% -12.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 20.6%
FY23 Q4 7.5%
FY24 Q1 -3.4%
FY24 Q2 -11.3%
FY24 Q3 -13.2%
FY24 Q4 -15.0%
FY25 Q1 -2.3%
FY25 Q2 10.5%
FY25 Q3 12.1%
FY25 Q4 17.0%
FY26 Q1 -0.9%
FY26 Q2 -12.7%
Operating margin (TTM) Seer, Inc.
-800% -600% -400% -200% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -631.0% Operating margin (TTM), FY23 Q4: -621.0% Operating margin (TTM), FY24 Q1: -645.7% Operating margin (TTM), FY24 Q2: -681.0% Operating margin (TTM), FY24 Q3: -676.6% Operating margin (TTM), FY24 Q4: -706.4% Operating margin (TTM), FY25 Q1: -624.7% Operating margin (TTM), FY25 Q2: -546.9% Operating margin (TTM), FY25 Q3: -513.5% Operating margin (TTM), FY25 Q4: -470.5% Operating margin (TTM), FY26 Q1: -491.3% Operating margin (TTM), FY26 Q2: -498.2% -498.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -631.0%
FY23 Q4 -621.0%
FY24 Q1 -645.7%
FY24 Q2 -681.0%
FY24 Q3 -676.6%
FY24 Q4 -706.4%
FY25 Q1 -624.7%
FY25 Q2 -546.9%
FY25 Q3 -513.5%
FY25 Q4 -470.5%
FY26 Q1 -491.3%
FY26 Q2 -498.2%
FCF margin (TTM) Seer, Inc.
-600% -400% -200% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -437.2% FCF margin (TTM), FY23 Q4: -398.4% FCF margin (TTM), FY24 Q1: -370.9% FCF margin (TTM), FY24 Q2: -360.3% FCF margin (TTM), FY24 Q3: -347.8% FCF margin (TTM), FY24 Q4: -350.7% FCF margin (TTM), FY25 Q1: -330.2% FCF margin (TTM), FY25 Q2: -334.8% FCF margin (TTM), FY25 Q3: -281.3% FCF margin (TTM), FY25 Q4: -279.0% FCF margin (TTM), FY26 Q1: -328.9% FCF margin (TTM), FY26 Q2: -311.1% -311.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -437.2%
FY23 Q4 -398.4%
FY24 Q1 -370.9%
FY24 Q2 -360.3%
FY24 Q3 -347.8%
FY24 Q4 -350.7%
FY25 Q1 -330.2%
FY25 Q2 -334.8%
FY25 Q3 -281.3%
FY25 Q4 -279.0%
FY26 Q1 -328.9%
FY26 Q2 -311.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 1 7 15 17 14 17 14
Gross profit 1 3 7 9 7 8 7
EBITDA −32 −69 −93 −98 −94 −73 −66
Operating income −34 −71 −97 −103 −100 −78 −71
Net income −33 −71 −93 −86 −87 −74 −68
Diluted EPS −$2.48 −$1.17 −$1.49 −$1.35 — — —
Growth (year on year)
Revenue — +908.7% +134.1% +7.5% −15.0% +17.0% −12.7%
Margins
Gross margin 100.0% 51.6% 45.8% 51.1% 49.8% 51.1% 47.7%
EBITDA margin <−999% <−999% −602.4% −588.9% −665.2% −439.6% −465.5%
Operating margin <−999% <−999% −627.6% −621.0% −706.4% −470.5% −498.2%
Net margin <−999% <−999% −600.1% −517.8% −611.1% −444.0% −478.0%
Free-cash-flow margin <−999% −805.0% −458.6% −398.4% −350.7% −279.0% −311.1%
Cash flow
Cash from operations −21 −46 −61 −59 −46 −44 −43
Capital spending 5 7 10 7 4 2 1
Free cash flow −25 −53 −71 −66 −50 −46 −44
Stock-based pay 7 26 34 34 28 15 11
Free cash flow after stock pay −33 −79 −105 −101 −78 −62 −55
Balance sheet
Cash 334 233 53 32 41 47 26
Total debt 0 0 0 0 0 0 0
Net debt (negative = net cash) −334 −233 −53 −32 −41 −47 −26
Diluted shares 13m 61m 62m 64m — — —
Returned to shareholders
Buybacks 0 0 0 0 0 — —
Total returned 0 0 0 0 0 — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $257m
Short-term assets $166mLonger-term assets $91m
What it owes, and who funded it · $257m
Short-term liabilities $11mLonger-term liabilities $20mShareholders' equity $226m
  • Short-term assets cover short-term liabilities $166m of assets due within a year against $11m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $166m short-term assets against $20m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Seer, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

R&D spending
264.1%
of revenue
Sales & admin spending
281.7%
of revenue

Competitors: side by side with peers

Closest by revenue in life sciences tools & services
Last 12 months unless stated SEER BNGO MXCT RPID OABI TKNO Median
Revenue, last 12 months $14m $30m $31m $35m $40m $44m $229m
Revenue growth, last 12 months −12.7% 10.0% −13.2% 16.1% 90.6% 12.3% 6.9%
Revenue growth, 3-year average −5.1% −1.4% −8.6% 22.5% −14.7% 3.7% 2.9%
Revenue growth, latest quarter −23.4% 21.4% −14.5% 10.9% 78.3% 18.5% 8.5%
Gross margin 47.7% 47.5% 79.2% — — 34.6% 51.9%
Operating margin −498.2% −106.7% −134.6% −141.5% −115.9% −36.2% −14.3%
Operating margin, 3-year average −575.4% −293.0% −128.7% −171.1% −278.2% −61.6% −22.4%
Net margin −478.0% −106.6% −114.8% −145.6% −108.1% −38.4% −16.1%
Cash from operations / revenue −305.1% −67.9% −74.0% −113.9% 6.6% −14.4% 1.3%
Free-cash-flow margin −311.1% −67.9% −76.1% −114.8% 5.9% −16.8% −2.2%
Free-cash-flow margin, 3-year average −335.4% −150.1% −79.7% −143.5% −130.3% −32.0% 0.6%
Stock pay / revenue 74.3% 11.6% 16.0% 12.3% 32.7% 6.7% 4.4%
Change in share count 0.2% — 1.0% 4.4% 19.2% 1.0% 1.0%

Median of all 54 companies we cover in life sciences tools & services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

54 life sciences tools & services companies
Measure Company Peer median Rank
Revenue growth Growth -12.7% 6.9% 49 of 54
Change in growth rate Growth -11.8pp +0.4pp 51 of 54
Gross margin Profitability 47.7% 52.0% 26 of 45
Operating margin Profitability -498.2% -14.3% 48 of 52
Net margin Profitability -478.0% -12.2% 50 of 54
Free-cash-flow margin Cash generation -311.1% -1.3% 50 of 54
Stock pay as % of revenue Cash generation 74.3% 4.4% 50 of 53

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$34M
Institutions reporting
59
Shares held vs prior quarter
▼ 3.9%
Positions opened / closed
9 / 8

Top buyers and sellers, Q2 2026: 23 institutions bought and 27 sold ; the biggest buyer was Citadel Advisors LLC (+519K shares) and the biggest seller Aju Ib Investment Co., Ltd (−816K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Softbank Group Corp. $8.5M 5.1M 25.0% 0.0%
Siren, L.L.C. $4.1M 2.5M 12.0% 0.0%
Acadian Asset Management LLC $3.2M 2.0M 9.5% ▼ 5.8%
Vanguard Capital Management LLC $3M 1.8M 8.9% ▼ 6.5%
Blackrock, Inc. $2.4M 1.4M 7.0% ▼ 21.6%
Renaissance Technologies LLC $1.6M 986K 4.8% ▲ 0.9%
Nano Cap New Millennium Growth Fund L P $1.4M 825K 4.0% 0.0%
Citadel Advisors LLC $862,055 519K 2.5% New
Two Sigma Investments, LP $817,215 492K 2.4% ▼ 3.8%
Geode Capital Management, LLC $764,512 460K 2.2% ▲ 8.9%
Bridgeway Capital Management, LLC $762,675 459K 2.2% 0.0%
Peapod Lane Capital LLC $739,447 445K 2.2% ▲ 1.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Seer, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $194,404 7 trades by 3 insiders · 12% under pre-set plans
Net ▼ $194,404 net selling
Insider Date Trade Shares Price Value
Horn David R. PRESIDENT & CFO August 18, 2026 Sell 7,309 $2.03 $14,837
Nishar Dipchand Director July 8, 2026 Sell pre-set plan 10,660 $2.18 $23,239
Horn David R. PRESIDENT & CFO May 20, 2026 Sell 7,303 $1.69 $12,342
Farokhzad Omid CEO AND CHAIR February 18, 2026 Sell 24,385 $1.99 $48,526
Horn David R. PRESIDENT & CFO February 18, 2026 Sell 7,743 $1.99 $15,409
Farokhzad Omid CEO AND CHAIR November 19, 2025 Sell 33,838 $1.97 $66,661
Horn David R. PRESIDENT & CFO November 19, 2025 Sell 6,797 $1.97 $13,390

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 5, 2026 estimated from the company's past filing pattern, not announced

  • August 11, 2026
  • May 13, 2026
  • February 26, 2026
  • November 6, 2025
  • August 6, 2025
  • May 13, 2025

Recent SEC filings

Data status

When each part of this page on Seer, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Seer, Inc. in brief

What does Seer, Inc. do?
Seer, Inc. is a US-listed company in the life sciences tools & services industry. Its financial year ends in December.
What is Seer, Inc.'s stock ticker?
Seer, Inc. trades under the ticker SEER on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Seer, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Seer, Inc. reported revenue of $14.2M, 12.7% lower than a year earlier, according to its SEC filings.
What is Seer, Inc.'s free cash flow?
Seer, Inc.'s free-cash-flow margin is -311.1% of revenue over the trailing twelve months, ranking 50 of the 54 life sciences tools & services companies we cover.
Who are Seer, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Softbank Group Corp., Siren, L.L.C. and Acadian Asset Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Seer, Inc.'s market cap?
On December 29, 2023, Seer, Inc.'s market capitalisation was about $124M and net debt of -$32.5M. Market figures come from third-party market data and may be delayed.
Who are Seer, Inc.'s competitors?
In our Life Sciences Tools & Services peer group, the companies closest to Seer, Inc. are Bionano Genomics, Inc., Maxcyte, Inc., Rapid Micro Biosystems, Inc., Omniab, Inc. and Alpha Teknova, Inc. The side-by-side comparison below sets their revenue, margins and growth against Seer, Inc.'s.
Are insiders buying or selling Seer, Inc. stock?
Over the last 12 months, Seer, Inc.'s directors and officers reported 0 open-market purchases and 7 sales on Form 4. The insider trading page charts every trade.
When is Seer, Inc.'s next earnings date?
Around November 10, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Seer, Inc. announces its own schedule.